ICU Medical, Inc. $ICUI Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lowered its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 45.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 6,013 shares of the medical instruments supplier’s stock after selling 4,961 shares during the period. Nisa Investment Advisors LLC’s holdings in ICU Medical were worth $721,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. River Road Asset Management LLC grew its holdings in ICU Medical by 207.0% during the second quarter. River Road Asset Management LLC now owns 651,492 shares of the medical instruments supplier’s stock worth $83,658,000 after acquiring an additional 439,263 shares during the period. Norges Bank acquired a new position in ICU Medical in the second quarter valued at approximately $36,633,000. William Blair Investment Management LLC purchased a new stake in ICU Medical in the 2nd quarter worth approximately $27,928,000. The Manufacturers Life Insurance Company grew its stake in shares of ICU Medical by 75.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 228,909 shares of the medical instruments supplier’s stock worth $30,250,000 after purchasing an additional 98,147 shares during the period. Finally, Quantinno Capital Management LP increased its holdings in shares of ICU Medical by 129.9% during the 2nd quarter. Quantinno Capital Management LP now owns 135,142 shares of the medical instruments supplier’s stock valued at $17,859,000 after purchasing an additional 76,352 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 930 shares of ICU Medical stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $142.34, for a total transaction of $132,376.20. Following the sale, the vice president owned 5,456 shares of the company’s stock, valued at $776,607.04. The trade was a 14.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Elisha W. Finney sold 1,285 shares of the company’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $140.42, for a total transaction of $180,439.70. Following the sale, the director directly owned 3,995 shares of the company’s stock, valued at $560,977.90. The trade was a 24.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.50% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on ICUI shares. Weiss Ratings reissued a “sell (d-)” rating on shares of ICU Medical in a report on Wednesday, October 8th. Wall Street Zen cut ICU Medical from a “buy” rating to a “hold” rating in a research report on Sunday, January 11th. Piper Sandler lifted their price target on ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Finally, KeyCorp increased their price target on ICU Medical from $173.00 to $175.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, ICU Medical presently has an average rating of “Moderate Buy” and a consensus target price of $175.67.

ICU Medical Stock Up 4.4%

ICUI opened at $155.12 on Friday. The company has a market cap of $3.83 billion, a PE ratio of -500.37 and a beta of 0.80. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $175.51. The company has a 50-day moving average price of $145.05 and a 200 day moving average price of $132.00. The company has a quick ratio of 1.19, a current ratio of 2.45 and a debt-to-equity ratio of 0.62.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $2.03 EPS for the quarter, topping the consensus estimate of $1.43 by $0.60. ICU Medical had a positive return on equity of 7.71% and a negative net margin of 0.32%.The company had revenue of $533.30 million during the quarter, compared to analyst estimates of $511.46 million. During the same period in the previous year, the business earned $1.59 EPS. ICU Medical’s quarterly revenue was down 8.9% on a year-over-year basis. ICU Medical has set its FY 2025 guidance at 7.350-7.650 EPS. Sell-side analysts expect that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.